ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Biodesix Inc

Biodesix Inc (BDSX)

1.45
0.00
(0.00%)
Closed May 29 4:00PM
1.45
0.00
(0.00%)
After Hours: 7:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.45
Bid
1.31
Ask
1.59
Volume
36,813
1.39 Day's Range 1.54
1.03 52 Week Range 2.21
Market Cap
Previous Close
1.45
Open
1.45
Last Trade
1
@
1.4
Last Trade Time
Financial Volume
$ 52,657
VWAP
1.4304
Average Volume (3m)
140,498
Shares Outstanding
96,942,061
Dividend Yield
-
PE Ratio
-2.70
Earnings Per Share (EPS)
-0.54
Revenue
49.09M
Net Profit
-52.15M

About Biodesix Inc

Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic researc... Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Headquarters
Wilmington, Delaware, USA
Founded
1970
Biodesix Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker BDSX. The last closing price for Biodesix was $1.45. Over the last year, Biodesix shares have traded in a share price range of $ 1.03 to $ 2.21.

Biodesix currently has 96,942,061 shares outstanding. The market capitalization of Biodesix is $140.57 million. Biodesix has a price to earnings ratio (PE ratio) of -2.70.

BDSX Latest News

Biodesix to Participate in Two Investor Conferences in June

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer, will participate in two upcoming...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.11-7.051282051281.561.591.391185071.5019935CS
40.1915.07936507941.261.63171.21011136471.50885399CS
12-0.07-4.605263157891.521.63171.151404981.40905512CS
26-0.1-6.451612903231.552.211.151344921.60236025CS
520.010.6944444444441.442.211.031013681.55976318CS
156-12.78-89.810260014114.2316.3950.9551667292.92489478CS
260-12.14-89.330389992613.5931.990.9551625615.02775846CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STSSSharps Technology Inc
$ 0.5289
(146.80%)
302.08M
AWINAERWINS Technologies Inc
$ 8.99
(139.10%)
5.41M
INSMInsmed Inc
$ 48.107
(118.67%)
33.42M
GVVisionary Holdings Inc
$ 0.38
(90.00%)
10.33M
SOBRSOBR Safe Inc
$ 0.41
(82.22%)
130.83M
APDNApplied DNA Sciences Inc
$ 0.580601
(-70.82%)
9.46M
LUCYInnovative Eyewear Inc
$ 0.40
(-59.31%)
85M
MRAIMarpai Inc
$ 0.90
(-53.61%)
803.83k
TOIIWOncology Institute Inc
$ 0.021
(-52.60%)
293.22k
SHOTWSafety Shot Inc
$ 0.21
(-36.07%)
24.26k
PEGYPineapple Energy Inc
$ 0.2595
(45.70%)
676.68M
GWAVGreenwave Technology Solutions Inc
$ 0.0782
(-7.89%)
306.67M
STSSSharps Technology Inc
$ 0.5289
(146.80%)
302.08M
CRKNCrown Electrokinetics Corporation
$ 0.1073
(6.24%)
232.62M
OBLGOblong Inc
$ 0.21
(19.32%)
146.15M

BDSX Discussion

View Posts
AJ Freely AJ Freely 11 months ago
$BDSX - Up 12%/ Current Price $1.34.
Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
👍️0
1hot toddy 1hot toddy 2 years ago
WOOOOOOW 130K SHARES BUY NOW 2.6 MIL SHARE BUY $

3 MILLION $ BUY $$$$$$$$$$$$$$$$$$$$$$
👍️0
Leg58 Leg58 2 years ago
Lots if potential but will public offering dilute price?
👍️0
Leg58 Leg58 2 years ago
Lots if potential but will public offering dilute price?
👍️0
subslover subslover 2 years ago
Earnings look good.
👍️0
subslover subslover 2 years ago
Earnings look good.
👍️0
MiamiGent MiamiGent 2 years ago
BDSX Has news this morning!

The contract covers the company’s entire lung diagnostic portfolio: Nodify XL2®, Nodify CDT®, VeriStrat®, GeneStrat® ddPCR, and GeneStrat NGS™ testing.

https://investors.biodesix.com/news-releases/news-release-details/biodesix-awarded-us-federal-supply-schedule-contract-its

https://stockcharts.com/h-sc/ui?s=BDSX
👍️0
carusso carusso 2 years ago
Not so much...
👍️0
crudeoil24 crudeoil24 2 years ago
LET'S GO BDSX !!!!!
👍️0
crudeoil24 crudeoil24 2 years ago
Biodesix to Participate in Two Upcoming Investor Conferences in September
6:00 am ET September 6, 2022 (BusinessWire) Print
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences:

Morgan Stanley 20th Annual Global Healthcare Conference Date: Tuesday, September 13, 2022 at 9:10 a.m. ET Format: Fireside Chat and 1x1 meetings Location: Sheraton Hotel, New York, NY Details: The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the Company's website at www.biodesix.com.

H.C. Wainwright 24th Annual Global Investment Conference Dates: September 12-14, 2022 Format: 1x1 meetings Location: Lotte New York Palace Hotel, New York, NY
👍️0
crudeoil24 crudeoil24 2 years ago
Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company’s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.
👍️0
Leg58 Leg58 2 years ago
US based company is quietly trending up. IMHO.
GLTA
👍️0